425
Participants
Start Date
September 17, 2018
Primary Completion Date
September 1, 2031
Study Completion Date
September 1, 2031
Contrast Agent
Given IV
Magnetic Resonance Imaging
Undergo MRI
Quality-of-Life Assessment
Ancillary studies
Questionnaire Administration
Ancillary studies
RECRUITING
M D Anderson Cancer Center, Houston
National Cancer Institute (NCI)
NIH
M.D. Anderson Cancer Center
OTHER